Brief: New Data To Be Shared At Asco 2022 Underscore Clinical Utility Of Decipher Prostate Genomic Classifier
27/05/2022 24:55
May 26 (Reuters) - Veracyte Inc VCYT.O :
* NEW DATA TO BE SHARED AT ASCO 2022 UNDERSCORE CLINICAL
UTILITY
OF DECIPHER PROSTATE GENOMIC CLASSIFIER
Source text for Eikon: ID:nBw2W0BKxa
Further company coverage: VCYT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina